Navigation Links
Echo Therapeutics Announces Third Quarter 2012 Financial Results
Date:11/8/2012

PHILADELPHIA, Nov. 8, 2012 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its needle-free Symphony® tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced its financial results for the quarter ended September 30, 2012. Echo's Quarterly Report on Form 10-Q, as filed with the SEC, will be available by visiting the Investors section of Echo's website at www.echotx.com.

(Logo:  http://photos.prnewswire.com/prnh/20120801/NE50071LOGO )

Recent Corporate Highlights

  • In preparation for its planned first quarter 2013 ISO audit, Echo made substantial advances towards finalizing its quality management systems.  ISO certification is a key step towards achieving compliance with European regulatory requirements.
  • Echo initiated the process of conducting clinical studies at investigational sites in Europe and the U.S. to support CE Mark and other commercialization efforts.
  • Echo hired key development, product, and clinical personnel to prepare for and accelerate its plans for Symphony's European and U.S. regulatory clearance and commercialization.
  • "We had a very productive third quarter, with significant progress made towards the Company's clinical, development and regulatory objectives needed to commercialize our Symphony system," commented Patrick T. Mooney, M.D., Chairman and Chief Executive Officer of Echo Therapeutics.  "As we look toward 2013, we remain focused on obtaining European clearance of Symphony and its commercial launch, as well as initiating our pivotal studies to support PMA submission in the U.S."

    Third Quarter 2012 Financial Results
    Echo's net loss for the third quarter of 2012 was $4.3 mil
    '/>"/>

    SOURCE Echo Therapeutics, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
    2. Particle Sciences Develops Novel Ocular Formulation for Eyeon Therapeutics
    3. Halozyme Therapeutics To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
    4. Novelos Therapeutics Closes $2 Million Private Placement
    5. US Allows Two Key Patents for Silence Therapeutics
    6. United Therapeutics Corporation Reports Third Quarter 2012 Financial Results
    7. Cell Therapeutics, Inc. (CTI) Reduces Net Loss for Third Quarter and Nine Months Ended September 30, 2012 Compared to Same Periods in 2011
    8. Novelos Therapeutics Announces Enrollment of First Patient in Solid Tumor Imaging Trial with I-124-CLR1404 (LIGHT) Cancer-targeted PET Imaging Agent at UW Carbone Cancer Center
    9. United Therapeutics Announces Collaboration With Ascendis Pharma To Develop Self-Injectable Treprostinil For Pulmonary Arterial Hypertension
    10. Mersana Therapeutics Named a "Fierce 15" Biotech Company for 2012
    11. Cell Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Rule
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/16/2014)... DIEGO , Sept. 16, 2014 /PRNewswire/ ... and manufacturing, announced that Mr. Greg Weilersbacher joined ... Control on August 25, 2014. Greg ... pharmaceutical industry experience with focused expertise in Quality ... Mr. Weilersbacher brings to Formex ...
    (Date:9/16/2014)... Sept. 16, 2014 On September 25 to ... focusing on medical design and manufacturing - MEDTEC China ... World Expo Exhibition & Convention Center, bringing together close ... regions to showcase their latest medical-grade raw materials, parts ... one week remaining for free visitor pre-registration to be ...
    (Date:9/16/2014)... CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), ... therapeutic products for the prevention and treatment of ... and restatement of its outstanding Series C-2, C-3, ... as well as the warrants issued in its ... remove anti-dilution, price reset and certain change of ...
    Breaking Medicine Technology:Greg Weilersbacher Joins Formex, LLC As Director of Quality Assurance and Quality Control 2MEDTEC China 2014: Seven Highlights Not to Miss! 2MEDTEC China 2014: Seven Highlights Not to Miss! 3MEDTEC China 2014: Seven Highlights Not to Miss! 4CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 2CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 3
    ... April 11, 2012  On April 16, the U.S. Supreme Court ... Labor Standards Act, Christopher v. SmithKline Beecham Corp. ... representatives are eligible to receive overtime pay. The larger issue ... of Labor,s interpretation of that statute. The ...
    ... N.C., April 10, 2012  TSI Healthcare announced today ... attested to successfully meeting "Meaningful Use" requirements of ... Systems. These providers completed data collection last year ... period for the Federal Government sponsored EHR Incentives ...
    Cached Medicine Technology:Supreme Court to Decide Overtime Fate for Pharmaceutical "Sales Representatives" -- JacksonWhite, Kingsley & Kingsley and Sanford Wittels & Heisler 2Supreme Court to Decide Overtime Fate for Pharmaceutical "Sales Representatives" -- JacksonWhite, Kingsley & Kingsley and Sanford Wittels & Heisler 3TSI Healthcare Customers Receive Government Incentives for Meeting EHR Requirements 2
    (Date:9/16/2014)... An experienced review website, Top10BestSEOHosting.com, has recently ... Bluehost and HostGator.com are among the best hosting ... high quality web hosting (including VPS and cloud ... now. , BlueHost ( http://www.bluehost.com/track/seohosts ) has ... a reliable and long-standing force in the world ...
    (Date:9/16/2014)... The second federal bellwether trial involving ... subsidiary Ethicon concluded with the jury in the case ... her $3.27 million in damages, according to a September ... found Ethicon liable for selling faulty devices and failing ... at risk from side effects that include pain, bleeding ...
    (Date:9/16/2014)... HealthDay Reporter TUESDAY, Sept. 16, 2014 ... human papillomavirus (HPV), which is linked to the risk of ... that testing urine for HPV has good accuracy when compared ... lead researcher Dr. Neha Pathak. She is a resident in ... of London, England. The test could be done at ...
    (Date:9/16/2014)... September 16, 2014 Not all recovery ... take care to make sure all their patients are ... some, this may include the newly-introduced online therapy. Millennium ... which gives patients the opportunity to seek treatment from ... provide medical and clinical care at a distance. They ...
    (Date:9/16/2014)... in helping people to reach their fitness and ... wearers improve their wellness by constantly monitoring their ... into companion computer programs and mobile apps. ... for these devices, researchers at the University of ... these activity monitors, such as those made by ...
    Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com: BlueHost and HostGator.com Are Among the Best Hosting Suppliers in 2014 2Health News:Ethicon to Appeal Bellwether Trial Verdict of $3.27 Million, Rottenstein Law Group LLP Notes 2Health News:Urine Test for HPV Works Well, Analysis Finds 2Health News:Millennium Treatment Group Now Offers Online Therapy 2Health News:Do wearable lifestyle activity monitors really work? 2Health News:Do wearable lifestyle activity monitors really work? 3
    ... a snack between breakfast and lunch lose less weight compared ... a study led by researchers at Fred Hutchinson Cancer Research ... McTiernan, M.D., Ph.D., a member of the Hutchinson Center,s Public ... be published in the December issue of the Journal ...
    ... moment to go with a method Princeton University researchers ... the chances of an unexpected yet groundbreaking chemical discovery. ... Science a technique to accomplish "accelerated serendipity" ... reactions a day with molecules never before combined. In ...
    ... release is available in French . , ... consequences than previously believed. Recent data suggests that individuals who ... to have a heart attack compared to individuals who are ... until now. A new study led by Concordia University ...
    ... of recent experiences. Scientists from Ludwig-Maximilians-Universitt (LMU) in ... subjects to estimate distances in a virtual reality ... approach the mean of all previously experienced distances. ... accurately predict the experimental findings using a mathematical ...
    ... London, November 28, 2011 - Serious global discussions have begun ... of 2015. Governments and international agencies are asking what has ... best to proceed after the deadline. Against this backdrop, a ... Health Matters finds that "quick impact" strategies, which may ...
    ... NJ. November 23, 2011. Kessler Foundation received two ... race/ethnicity, and socioeconomic status on the rehabilitation and ... grants totalling $296,261 were awarded to Denise Fyffe, ... Injury/Outcomes & Assessment Laboratories. Dr. Fyffe, a clinical ...
    Cached Medicine News:Health News:Mid-morning snacking may sabotage weight-loss efforts 2Health News:Mid-morning snacking may sabotage weight-loss efforts 3Health News:Princeton technique puts chemistry breakthroughs on the fast track 2Health News:Princeton technique puts chemistry breakthroughs on the fast track 3Health News:Princeton technique puts chemistry breakthroughs on the fast track 4Health News:Princeton technique puts chemistry breakthroughs on the fast track 5Health News:Depression can lead to heart disease 2Health News:When errors improve performance: Model describes how experiences influence our perception 2Health News:Good intentions may hamper progress in pursuit of global reproductive health and rights 2Health News:Kessler Foundation receives grants to study health disparities in people with disabilities 2
    Used to introduce balloon, electrode, closed or non-tapered end catheters and other devices for intervention....
    Used to introduce balloon, closed and non-tapered end catheters or other devices for intervention....
    Sheath Introducers with guidewires....
    Used to introduce balloon, electrode, closed or non-tapered end and,other catheters....
    Medicine Products: